| 1 | A Comparison of Two Statistical Mapping Tools for Automated Brain FDG-PET Analysis in Predicting Conversion to Alzheimer's Disease in Subjects with Mild Cognitive Impairment. | Current Alzheimer Research | Valentina Garibotto; Sara Trombella; Luigi Antelmi; Paolo Bosco; Alberto Redolfi; Claire Tabouret-Viaud; Olivier Rager; Gabriel Gold; Panteleimon Giannakopoulos; Silvia Morbelli; Flavio Nobili; Robert Perneczky; Mira Didic; Eric Guedj; Alexander Drzezga; | 10.2174/1567205018666210212162443 | 0 |
| 2 | Novel Variants of DOCK8 Deficiency in a Case Series of Iranian Patients. | Endocrine, Metabolic & Immune Disorders Drug Targets | Sara Momtazmanesh; Elham Rayzan; Samaneh Zoghi; Sepideh Shahkarami; Rasol Molatefi; Iraj Mohammadzadeh; Javad Ghaffari; Hamidreza Mahmoudi; Jasmin Dmytrus; Anna Segarra-Roca; Ido Somekh; Maximilian Witzel; Fabian Hauck; Kaan Boztug; Christoph Klein; Nima | 10.2174/1871530321666210226143912 | 0 |
| 3 | Metal-organic Nanopharmaceuticals. | Pharmaceutical Nanotechnology | Benjamin Steinborn; Ulrich Lächelt | 10.2174/2211738508666200421113215 | 0 |
| 4 | Differences in Kynurenine Metabolism During Depressive, Manic, and Euthymic Phases of Bipolar Affective Disorder. | Current Topics In Medicinal Chemistry | Alexander Maget; Martina Platzer; Susanne Bengesser; Frederike T. Fellendorf; Armin Birner; Robert Queissner; Carlo Hamm; Bernd Reininghaus; Andrzej Hecker; Lukas Tomberger; Rene Pilz; Nina Dalkner; Natalie Moll; Gregor Schütze; Markus J. Schwarz; Hans Pe | 10.2174/1568026619666190802145128 | 4 |
| 5 | Dimethylformamide Acetals and Bredereck’s Reagent as Building Blocks in Natural Products Total Synthesis | Mini-Reviews In Organic Chemistry | Franz Bracher | 10.2174/1570193x16666181204122143 | 1 |
| 6 | A Short Synthesis of the Plant Alkaloid 4-Methyl-2,6-naphthyridine | Letters In Organic Chemistry | Alexandra Kamlah and Franz Bracher | 10.2174/1570178616666181116110647 | 2 |
| 7 | Reviewing the Mechanistic Evidence Assessors E-Synthesis and EBM+: A Case Study of Amoxicillin and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). | Current Pharmaceutical Design | Ahmad Yaman Abdin; Daniel Auker-Howlett; Jürgen Landes; Glorjen Mulla; Claus Jacob; Barbara Osimani | 10.2174/1381612825666190628160603 | 6 |
| 8 | Meet Our Editorial Board Member | Pharmaceutical Nanotechnology | Ulrich Lächelt | 10.2174/221173850701190412105539 | 0 |
| 9 | Metal Ion Complexes with Pyrazoles, Aziridines and Diaziridines – Synthesis and Biological Activity | Current Medicinal Chemistry | Katarzyna Malinowska; Ingo-Peter Lorenz; Beata Sadowska; Paulina Mucha | 10.2174/0929867325666180221124447 | 5 |
| 10 | Advances in the Development of Anticancer HSP-based Vaccines. | Current Medicinal Chemistry | Alexey V. Baldin; Andrey A. Zamyatnin; Alexandr V. Bazhin; Wanhai Xu; Lyudmila V. Savvateeva | 10.2174/0929867325666180129100015 | 4 |
| 11 | Extracellular Nucleic Acids in Health and Disease. | Current Pharmaceutical Biotechnology | Anna-Kristina Kluever; Elisabeth Deindl | 10.2174/138920101915190125142421 | 0 |
| 12 | Extracellular RNA, a Potential Drug Target for Alleviating Atherosclerosis, Ischemia/Reperfusion Injury and Organ Transplantation | Current Pharmaceutical Biotechnology | Anna-Kristina Kluever; Elisabeth Deindl | 10.2174/1389201020666190102150610 | 3 |
| 13 | New Resensitizers for the Nicotinic Acetylcholine Receptor by Ligand-Based Pharmacophore Modeling. | Current Computer-aided Drug Design | Thomas Wein; Klaus T. Wanner; Sebastian Rappenglück; Sonja Sichler; Karin V. Niessen; Thomas Seeger; Franz Worek; Horst Thiermann | 10.2174/1573409914666180703120201 | 2 |
| 14 | Efficacy and Safety of Serotonin Receptor Ligands in the Treatment of Irritable Bowel Syndrome: A Review | Current Drug Targets | Agata Binienda; Martin Storr; Jakub Fichna; Maciej Sałaga | 10.2174/1389450119666171227225408 | 15 |
| 15 | Examining Insulin Adsorption onto Mesoporous Silica Microparticles for Oral Delivery | Current Drug Delivery | Sarah Youssef Eilleia; Mahmoud Eid Soliman; Stefan Niedermayer; Alexandra Schmidt; Samar Mansour; Ahmed S. Geneidi | 10.2174/1567201814666171002142023 | 1 |
| 16 | Macrophage Migration Inhibitory Factor - A Favorable Marker in Inflammatory Diseases? | Current Medicinal Chemistry | Johannes Hertelendy; Georg Reumuth; David Simons; Christian Stoppe; Bong-Sung Kim; Jan-Philipp Stromps; Paul Fuchs; Jürgen Bernhagen; Norbert Pallua; Gerrit Grieb | 10.2174/0929867324666170714114200 | 15 |
| 17 | Meet Our Editorial Board Member | Mini-Reviews In Organic Chemistry | Franz Bracher | 10.2174/1570193x1501180129154832 | 0 |
| 18 | Unmet Needs in Schizophrenia. | CNS & Neurological Disorders Drug Targets | Maurizio Pompili; Gloria Giordano; Mario Luciano; Dorian A. Lamis; Valeria Del Vecchio; Gianluca Serafini; Gaia Sampogna; Denise Erbuto; Peter Falkai; Andrea Fiorillo | 10.2174/1871527316666170803143927 | 8 |
| 19 | Topical Application of In Vitro Transcribed mRNA to the Airways as a Novel Gene Therapy Approach for the Treatment of Cystic Fibrosis | Clinical Immunology, Endocrine & Metabolic Drugs | Shan Guan; Sarah M. Johler; Carsten Rudolph; Joseph Rosenecker | 10.2174/2212707004666170502170037 | 0 |
| 20 | Tendon Repair Leads to better Long-Term Clinical Outcome than Debridement in Massive Rotator Cuff Tears. | The Open Orthopaedics Journal | Matthias König; Volker Braunstein | 10.2174/1874325001611010546 | 10 |
| 21 | The Molecular Mechanisms of Thalidomide Teratogenicity and Implications for Modern Medicine. | Current Molecular Medicine | J. Knobloch; David Jungck; Andrea Koch | 10.2174/1566524017666170331162315 | 6 |
| 22 | Genetic Imbalance in Patients with Cervical Artery Dissection. | Current Genomics | Caspar Grond-Ginsbach; Bowang Chen; Michael Krawczak; Rastislav Pjontek; Philip Ginsbach; Yanxiang Jiang; Sherine Abboud; M. Arnold; Anna Bersano; Tobias Brandt; Valeria Caso; Stéphanie Debette; Martin Dichgans; Andreas Geschwendtner; Giacomo Giacalone; J | 10.2174/1389202917666160805152627 | 16 |
| 23 | HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Crosssectional Design | Current HIV Research | Aubin Nanfack; Desire Takou; Joseph Fokam; Romina Salpini; Maria Mercedes Santoro; Giulia Cappelli; Martin Baane; Suzie Moyo Ndiang Tetang; Josef Eberle; Lutz Gürtler; Francesca Ceccherini-Silberstein; Judith Torimiro; Vittorio Colizzi; Carlo Federico Per | 10.2174/1570162x14666161230105417 | 3 |
| 24 | Playing Modular Puzzle with Adhesion/Growth-Regulatory Galectins: Design and Testing of a Hybrid to Unravel Structure-Activity Relationships | Protein And Peptide Letters | Anna-Kristin Ludwig; Sabine Vértesy; Malwina Michalak; Joachim C. Manning; Sabine André; Dieter Kübler; Jürgen Kopitz; Herbert Kaltner; Hans-Joachim Gabius | 10.2174/0929866523666160930123421 | 6 |
| 25 | Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects. | Current Alzheimer Research | Matthias Brendel; Veronika Reinisch; Eva Kalinowski; Johannes Levin; Andreas Delker; Sonja Därr; Oliver Pogarell; Stefan Förster; Peter Bartenstein; Axel Rominger; Alzheimer’s Disease Neuroimaging Initiative | 10.2174/1567205013666160314143922 | 7 |
| 26 | Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation. | Current Alzheimer Research | Marcus Högenauer; Matthias Brendel; Andreas Delker; Sonja Därr; M. Weiss; Peter Bartenstein; Axel Rominger; Alzheimer’s Disease Neuroimaging Initiative | 10.2174/156720501304160325175855 | 6 |
| 27 | Disruption of Circadian Rhythms and Sleep in Critical Illness and its Impact on Innate Immunity. | Current Pharmaceutical Design | Viola Dengler; Kristin Westphalen; Michael Koeppen | 10.2174/1381612821666150706105034 | 5 |
| 28 | Humans Entrain to Sunlight - Impact of Social Jet Lag on Disease and Implications for Critical Illness. | Current Pharmaceutical Design | Jan Rémi | 10.2174/1381612821666150706110228 | 8 |
| 29 | Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of Timing | Current Gene Therapy | Ulrich Siler; Anna Paruzynski; Heidi Holtgreve-Grez; Elena Kuzmenko; Ulrike Koehl; E.D. Renner; Canan Alhan; Arjan A. van de Loosdrecht; Joachim Schwäble; Thomas Pfluger; Joelle Tchinda; Markus Schmugge; Anna Jauch; Sonja Naundorf; Klaus Kühlcke; Gundula | 10.2174/1566523215666150515145255 | 46 |
| 30 | Current Management of Fetal and Neonatal Renal Tumors | Current Pediatric Reviews | Michael Berger; null von Schweinitz D | 10.2174/1573396311666150714105403 | 2 |
| 31 | Novel self-inactivating vectors for reconstitution of Wiskott-Aldrich syndrome. | Current Gene Therapy | Emanuele G. Coci; Tobias Maetzig; Daniela Zychlinski; Michael Rothe; Julia D. Suerth; Christoph Klein; Axel Schambach | 10.2174/1566523215666150126120327 | 4 |
| 32 | Impact of Dynamic Loading on the Implant-abutment Interface Using a Gas-enhanced Permeation Test In Vitro | The Open Dentistry Journal | Anas Al-Jadaa; Thomas Attin; Timo Peltomäki; Christian Heumann; Patrick R. Schmidlin | 10.2174/1874210601509010112 | 1 |
| 33 | Antibody recognition of fluorinated haptens and antigens | Current Topics In Medicinal Chemistry | Maximilian Reindl; Anja Hoffmann-Röder | 10.2174/1568026614666140202203811 | 11 |
| 34 | CNS transporters and drug delivery in epilepsy. | Current Pharmaceutical Design | Heidrun Potschka; Hiram Luna-Munguia | 10.2174/13816128113199990461 | 16 |
| 35 | Neuron-Specific Mitochondrial DNA Deletion Levels in Sporadic Alzheimer´s Disease | Current Alzheimer Research | Anne Gerschütz; Helmut Heinsen; Edna Grünblatt; Anne Kristin Wagner; Jasmin Bartl; Christoph Meissner; Andreas J. Fallgatter; Safa Al-Sarraj; Claire Troakes; Isidro Ferrer; Thomas Arzberger; Jürgen Deckert; Peter Riederer; Matthias Fischer; Thomas Tatschn | 10.2174/15672050113106660166 | 13 |
| 36 | Quantum Tunnelling to the Origin and Evolution of Life | Current Organic Chemistry | Frank Trixler | 10.2174/13852728113179990083 | 34 |
| 37 | Nuclear hormone receptors and female reproduction. | Current Molecular Medicine | Aurelia Pestka; J. S. Fitzgerald; B. Toth; U. R. Markert; U. Jeschke | 10.2174/1566524011313070002 | 15 |
| 38 | Buprenorphine and buprenorphine/naloxone intoxication in children - how strong is the risk? | Current Drug Abuse Reviews | Michael Soyka | 10.2174/18744737112059990010 | 8 |
| 39 | Content Validity of the Comprehensive ICF Core Set for Chronic Obstructive Pulmonary Diseases:An International Delphi Survey | The Open Respiratory Medicine Journal | Andrea Jobst; Inge Kirchberger; Alarcos Cieza; Gerold Stucki; Armin Stucki | 10.2174/1874306401307010033 | 10 |
| 40 | Transcranial brain stimulation in schizophrenia: targeting cortical excitability, connectivity and plasticity. | Current Medicinal Chemistry | Alkomiet Hasan; Peter Falkai; Thomas Wobrock | 10.2174/0929867311320030012; 10.2174/092986713804870738 | 44 |
| 41 | The Relationship between Tourette's Syndrome and Infections. | The Open Neurology Journal | Daniela Krause; Norbert Müller | 10.2174/1874205x01206010124 | 9 |
| 42 | Routine use of corticosteroids to prevent inflammation response in cardiac surgery. | Recent Patents On Cardiovascular Drug Discovery | Tim Nebelsiek; Andres Beiras-Fernandez; Erich Kilger; Patrick Möhnle; Florian Weis | 10.2174/157489012803832829 | 18 |
| 43 | In vivo imaging of the diseased nervous system: an update. | Current Pharmaceutical Design | Catherine D. Sorbara; Thomas Misgeld; Martin Kerschensteiner | 10.2174/138161212802502279 | 5 |
| 44 | Drug induced interstitial lung disease. | The Open Respiratory Medicine Journal | Martin Schwaiblmair; Werner Behr; Thomas Haeckel; Bruno Märkl; Wolfgang Foerg; Thomas M. Berghaus | 10.2174/1874306401206010063 | 163 |
| 45 | Platelet hyperreactivity and stent thrombosis in patients undergoing coronary stenting. | Current Vascular Pharmacology | Katharina Mayer; Dirk Sibbing | 10.2174/157016112801784666 | 5 |
| 46 | Functional magnetic resonance imaging and treatment strategies in schizophrenia. | Current Pharmaceutical Biotechnology | Susanne Karch; Oliver Pogarell; Christoph Mulert | 10.2174/138920112800784853 | 6 |
| 47 | Disturbed function of GABAergic interneurons in schizophrenia: relevance for medical treatment? | Current Pharmaceutical Biotechnology | Just Genius; Ina Giegling; Jens Benninghoff; Dan Rujescu | 10.2174/138920112800784943 | 6 |
| 48 | Pharmacotherapy of schizophrenic patients: achievements, unsolved needs, future research necessities. | Current Pharmaceutical Biotechnology | Hans-Jürgen Möller | 10.2174/138920112800784907 | 3 |
| 49 | Immunological treatment options for schizophrenia. | Current Pharmaceutical Biotechnology | Norbert Müller; Aye-Mu Myint; Markus J. Schwarz | 10.2174/138920112800784826 | 28 |
| 50 | The role of micafungin and anidulafungin in the treatment of systemic fungal infections: applications and patents for two novel echinocandins. | Recent Patents On Anti-infective Drug Discovery | Ludwig Christian Hinske; Florian Weis; Jens Heyn; Patricia M. Hinske; Andres Beiras Fernandez | 10.2174/157489112799829747 | 4 |
| 51 | Current progress in the genetic research of schizophrenia: relevance for drug discovery? | Current Pharmaceutical Biotechnology | Dan Rujescu; Just Genius; Jens Benninghoff; Ina Giegling | 10.2174/138920112800784754 | 4 |
| 52 | BACE1 dependent neuregulin processing: review. | Current Alzheimer Research | Daniel Fleck; Alistair N. Garratt; Christian Haass; Michael Willem | 10.2174/156720512799361637 | 57 |
| 53 | Umbilical cord lining membrane and wharton's jelly-derived mesenchymal stem cells: The similarities and differences | The Open Tissue Engineering And Regenerative Medicine Journal | Marc G. Jeschke; Gerd G. Gauglitz; Thang T. Phan; David N. Herndon; Katsuhiro Kita | 10.2174/1875043501104010021 | 31 |
| 54 | MicroRNAs as potential therapeutic agents in the treatment of myocardial infarction. | Current Vascular Pharmacology | Jens Heyn; Christian Hinske; Patrick Möhnle; Benjamin Luchting; Andres Beiras-Fernandez; Simone Kreth | 10.2174/157016111797484143 | 6 |
| 55 | Development of adenovirus hybrid vectors for Sleeping Beauty transposition in large mammals. | Current Gene Therapy | Martin Hausl; Wenli Zhang; Richard Voigtlander; Nadine Müther; Christina Rauschhuber; Anja Ehrhardt | 10.2174/156652311797415890 | 14 |
| 56 | Bortezomib Targets the Caspase-Like Proteasome Activity in Cervical Cancer Cells, Triggering Apoptosis That Can be Enhanced by Nelfinavir | Current Cancer Drug Targets | Ansgar Brüning; M. Vogel; I. Mylonas; K. Friese; A. Burges | 10.2174/156800911796798913 | 32 |
| 57 | “European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary | Current Vascular Pharmacology | Dimitri P. Mikhailidis; Moses Elisaf; Manfredi Rizzo; Kaspar Berneis; Bruce A. Griffin; Alberto Zambon; Vasilios G. Athyros; Jacqueline de Graaf; Winfried März; Klaus G. Parhofer; Giovam Battista Rini; Giatgen A. Spinas; Gerald H. Tomkin; Alexandros D. Ts | 10.2174/157016111796642698 | 105 |
| 58 | "European Panel on Low Density Lipoprotein (LDL) Subclasses": A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses | Current Vascular Pharmacology | Dimitri P. Mikhailidis; Moses Elisaf; Manfredi Rizzo; Kaspar Berneis; Bruce A. Griffin; Alberto Zambon; Vasilios G. Athyros; Jacqueline de Graaf; Winfried März; Klaus G. Parhofer; Giovam Battista Rini; Giatgen A. Spinas; Gerald H. Tomkin; Alexandros D. Ts | 10.2174/157016111796642661 | 168 |
| 59 | The role of integrins in glioma biology and anti-glioma therapies. | Current Pharmaceutical Design | Ghazaleh Tabatabai; Jörg C. Tonn; Roger Stupp; Michael Weller | 10.2174/138161211797249189 | 33 |
| 60 | Targeting ErbB receptors in high-grade glioma. | Current Pharmaceutical Design | Sabina Berezowska; Jürgen Schlegel | 10.2174/138161211797249233 | 31 |
| 61 | BACE1 Dependent Neuregulin Proteolysis. | Current Alzheimer Research | Daniel Fleck; Alistair N. Garratt; Christian Haass; Michael Willem | 9 | |
| 62 | Perspectives on Systematic Analyses of Gene Function in Arabidopsis thaliana: New Tools, Topics and Trends | Current Genomics | Cordelia Bolle; Anja Schneider; Dario Leister | 10.2174/138920211794520187 | 33 |
| 63 | Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects. | Current Pharmaceutical Design | Norbert Müller; Aye-Mu Myint; Markus J. Schwarz | 10.2174/138161211795049552 | 68 |
| 64 | Ghrelin, A Novel Peptide Hormone in the Regulation of Energy Balance and Cardiovascular Function | Recent Patents On Endocrine, Metabolic & Immune Drug Discovery | Carola Ledderose; Simone Kreth; Andres Beiras-Fernandez | 10.2174/187221411794351897 | 33 |
| 65 | The protective effects of levosimendan on ischemia/reperfusion injury and apoptosis. | Recent Patents On Cardiovascular Drug Discovery | Patrick Scheiermann; Andres Beiras-Fernandez; Haitham Mutlak; Florian Weis | 10.2174/157489011794578482 | 11 |
| 66 | Role of NFAT5 in inflammatory disorders associated with osmotic stress. | Current Genomics | Wolfgang Neuhofer | 10.2174/138920210793360961 | 80 |
| 67 | Interactions of Human Endothelial and Multipotent Mesenchymal Stem Cells in Cocultures | The Open Biomedical Engineering Journal | Christina Ern; Vera Krump-Konvalinkova; Denitsa Docheva; Stefanie Schindler; Oliver Rossmann; Wolfgang Böcker; Wolf Mutschler; Matthias Schieker | 10.2174/1874120701004010190 | 14 |
| 68 | Src tyrosine kinase inhibition suppresses lymphangiogenesis in vitro and in vivo. | Current Cancer Drug Targets | Ivan Ischenko; H. Seeliger; Peter Camaj; A. Kleespies; M. Guba; M. Eichhorn; Karl W. Jauch; C.J. Bruns | 10.2174/156800910791517181 | 9 |
| 69 | Immune System and Schizophrenia. | Current Immunology Reviews | Norbert Müller; Markus J. Schwarz | 10.2174/157339510791823673 | 224 |
| 70 | New Prospects for Nelfinavir in Non-HIV-Related Diseases | Current Molecular Pharmacology | Ansgar Brüning; Andrea Gingelmaier; Klaus Friese; Ioannis Mylonas | 10.2174/1874467211003020091 | 26 |
| 71 | What are the potential benefits of clinical beta-cell imaging in diabetes mellitus? | Current Pharmaceutical Design | Burkhard Göke | 10.2174/138161210791164081 | 11 |
| 72 | Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms. | Current Genomics | Benedikt Schoser; Lubov Timchenko | 10.2174/138920210790886844 | 79 |
| 73 | A Review on the risk of myocardial infarction associated with the NSAID diclofenac. | Cardiovascular & Hematological Disorders Drug Targets | Florian Krötz; Lena Struthmann | 10.2174/187152910790780041 | 14 |
| 74 | The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery | Current Cancer Drug Targets | Mohan Hingorani; Christine Spitzweg; Georges Vassaux; Kate Newbold; Alan Melcher; Hardev Pandha; Richard G. Vile; Kevin J. Harrington | 10.2174/156800910791054194 | 90 |
| 75 | Anticonvulsants in the treatment of aggression in the demented elderly: an update | Clinical Practice And Epidemiology In Mental Health : CP & EMH | Benedikt L. Amann; Johannes Pantel; Heinz Grunze; Eduard Vieta; Francesc Colom; Ana González-Pinto; Dieter Naber; Harald Hampel | 10.1186/1745-0179-5-14 | 14 |
| 76 | Inhibition of human aromatase by myosmine. | Drug Metabolism Letters | Irene L Doering; Elmar Richter | 10.2174/187231209788654045 | 5 |
| 77 | Adequate Patient Characterization in COPD: Reasons to Go Beyond GOLD Classification. | The Open Respiratory Medicine Journal | Matthias Griese; P Busch; D Caroli; B Mertens; C. Eismann; M Harari; H Staudter; M Kappler | 10.2174/1874306400903010001 | 26 |
| 78 | Cancer stem cells: how can we target them? | Current Medicinal Chemistry | Ivan Ischenko; Hendrik Seeliger; Moshe Schaffer; Karl-Walter Jauch; Christiane Bruns | 10.2174/092986708786848541 | 103 |
| 79 | Independent component analysis applied to pharmacological magnetic resonance imaging (phMRI): new insights into the functional networks underlying panic attacks as induced by CCK-4. | Current Pharmaceutical Design | Alica C. Dieler; Philipp G. Sämann; Gregor Leicht; Daniela Eser; Valerie Kirsch; Thomas C. Baghai; Susanne Karch; Cornelius Schüle; Oliver Pogarell; Michael Czisch; Rainer Rupprecht; Christoph Mulert | 10.2174/138161208786848801 | 13 |
| 80 | Neuroactive steroids as endogenous modulators of anxiety. | Current Pharmaceutical Design | Daniela Eser; Thomas C. Baghai; Cornelius Schüle; Caroline Nothdurfter; Rainer Rupprecht | 10.2174/138161208786848838 | 44 |
| 81 | Extracellular Targeting of Synthetic Therapeutic Nucleic Acid Formulations | Current Gene Therapy | Alexander Philipp; Martin Meyer; Ernst Wagner | 10.2174/156652308786071023 | 21 |
| 82 | Regulation of the endoplasmic reticulum Ca(2+)-store in cancer. | Anti-cancer Agents In Medicinal Chemistry | Bergner A; Huber Rm | 10.2174/187152008785914734 | 38 |
| 83 | Mesenchymal Stem Cells and Their Cell Surface Receptors | Current Rheumatology Reviews | Denitsa Docheva; Florian Haasters; Matthias Schieker | 10.2174/157339708785133479 | 46 |
| 84 | Episomal Vectors for Gene Therapy | Current Gene Therapy | Anja Ehrhardt; Rudolf Haase; Aloys Schepers; Manuel J. Deutsch; Hans J. Lipps; Armin Baiker | 10.2174/156652308784746440 | 60 |
| 85 | COX-2 Inhibition in Schizophrenia and Major Depression | Current Pharmaceutical Design | Norbert Müller; Markus J. Schwarz | 10.2174/138161208784480243 | 85 |
| 86 | A Survey of Chloroplast Protein Kinases and Phosphatases in Arabidopsis thaliana | Current Genomics | Ivo Schliebner; Mathias Pribil; Jessica Zühlke; Angela Dietzmann; Dario Leister | 10.2174/138920208784340740 | 45 |
| 87 | ANTI-ADHESION evolves to a promising therapeutic concept in oncology. | Current Medicinal Chemistry | R Schmidmaier; P Baumann | 10.2174/092986708784049667 | 92 |
| 88 | The catalytic core of gamma-secretase: presenilin revisited. | Current Alzheimer Research | Harald Steiner | 10.2174/156720508783954677 | 32 |
| 89 | Photochemical internalization: a new tool for drug delivery. | Current Pharmaceutical Biotechnology | Kristian Berg; Marco Folini; Lina Prasmickaite; Pål Kristian Selbo; Anette Bonsted; Birgit Engesæter; Nadia Zaffaroni; Anette Weyergang; Andreas Dietze; Gunhild Mari Mælandsmo; Ernst Wagner; Ole Jacob Norum; Anders Høgset | 10.2174/138920107783018354 | 106 |
| 90 | Movement of endosymbiotic organelles. | Current Protein & Peptide Science | Serena Schmidt von Braun; Enrico Schleiff | 10.2174/138920307782411437 | 13 |
| 91 | Emerging adenoviral vectors for stable correction of genetic disorders. | Current Gene Therapy | Lorenz Jäger; Anja Ehrhardt | 10.2174/156652307781369074 | 50 |
| 92 | Genetically engineered stem cells for therapeutic gene delivery | Current Gene Therapy | Claudius Conrad; Rashmi Gupta; Hema Mohan; Hanno Niess; Christiane J. Bruns; Reinhard Kopp; Irene von Luettichau; Markus Guba; Christopher Heeschen; Karl-Walter Jauch; Ralf Huss; Peter J. Nelson | 10.2174/156652307781369119 | 50 |
| 93 | Control by Substrate of the Cytochrome P450-Dependent Redox Machinery: Mechanistic Insights | Current Drug Metabolism | Peter Hlavica | 10.2174/138920007781368881 | 18 |
| 94 | Osmoadaptation of Mammalian cells - an orchestrated network of protective genes. | Current Genomics | Küper Christoph; Franz-X. Beck; Wolfgang Neuhofer | 10.2174/138920207781386979 | 29 |
| 95 | The vascular compartments of neovascularization: spotlight on the microcirculation. | Current Pharmaceutical Biotechnology | Christian Kupatt | 10.2174/138920107779941390 | 3 |
| 96 | Mast cell tryptase beta as a target in allergic inflammation: an evolving story. | Current Pharmaceutical Design | Christian P. Sommerhoff; Norbert Schaschke | 10.2174/138161207779313579 | 40 |
| 97 | Blockade of chemokine-mediated tissue injury in lupus nephritis. | Endocrine, Metabolic & Immune Disorders Drug Targets | Volker Vielhauer; Hans-Joachim Anders | 10.2174/187153006779025739 | 4 |
| 98 | Chemokines in Allergic Aspergillosis - From Animal Models to Human Lung Diseases | Inflammation & Allergy Drug Targets | Dominik Hartl; Karen F. Buckland; Cory M. Hogaboam | 10.2174/187152806779010972 | 34 |
| 99 | Prothrombotic Potential of NSAID in Ischemic Heart Diesase | Mini Reviews In Medicinal Chemistry | Florian Krötz; Nicole Hellwig; Thomas M. Schiele; Volker Klauss; Hae-Young Sohn | 10.2174/138955706778993030 | 6 |
| 100 | Nucleic acid based therapeutics for tumor therapy. | Anti-cancer Agents In Medicinal Chemistry | Manfred Ogris | 10.2174/187152006778699158 | 9 |
| 101 | Surfactant protein A--from genes to human lung diseases. | Current Medicinal Chemistry | S. Heinrich; D. Hartl; M. Griese | 10.2174/092986706778773112 | 28 |
| 102 | Nucleic acids modulate autoimmunity through nucleic-acid-specific toll-like receptors. | Current Medicinal Chemistry | Prashant S. Patole; Hans-Joachim Anders | 10.2174/092986706778521832 | 3 |
| 103 | Cyclooxygenase inhibition and atherothrombosis. | Current Drug Targets | Hae-Young Sohn; Florian Krötz | 10.2174/138945006778559102 | 21 |
| 104 | Thrombin inhibitors and anti-factor Xa agents in the treatment of arterial occlusion. | Current Drug Targets | V Klauss; M Spannagl | 10.2174/138945006778559148 | 5 |
| 105 | Molecular Insights into Mechanisms of the Cell Death Program:Role in the Progression of Neurodegenerative Disorders | Current Alzheimer Research | Carsten Culmsee; Stefan Landshamer | 10.2174/156720506778249461 | 138 |
| 106 | Lentiviral transgenesis--a versatile tool for basic research and gene therapy. | Current Gene Therapy | Alexander Pfeifer | 10.2174/156652306777934856 | 36 |
| 107 | Recent progress in pharmacological and non-pharmacological treatment options of major depression. | Current Pharmaceutical Design | Thomas C. Baghai; Hans-Jürgen Möller; Rainer Rupprecht | 10.2174/138161206775474422 | 52 |
| 108 | Targeted agents for the treatment of advanced renal cell carcinoma. | Current Drug Targets | Michael Staehler; K. Rohrmann; N. Haseke; C.G. Stief; M. Siebels | 10.2174/138945005774574498 | 71 |
| 109 | Enhancing the sensitivity of fluorescence correlation spectroscopy by using time-correlated single photon counting. | Current Pharmaceutical Biotechnology | Don C. Lamb; Barbara K. Müller; Christoph Bräuchle | 10.2174/138920105774370625 | 21 |
| 110 | The Application of Photofrin II as a sensitizing agent for ionizing radiation--a new approach in tumor therapy? | Current Medicinal Chemistry | Moshe Schaffer; Birgit Ertl-Wagner; Pamela Schaffer; Ulrike Kulka; Giulio Jori; Eckhart Dühmke; Alfons Hofstetter | 10.2174/0929867053764653 | 33 |
| 111 | Statin-induced vascular smooth muscle cell apoptosis: a possible role in the prevention of restenosis? | Current Drug Targets. Cardiovascular & Haematological Disorders | Wolfgang Erl | 10.2174/1568006043586134 | 35 |
| 112 | Specific Targets in Tumor Tissue for the Delivery of Therapeutic Genes | Current Medicinal Chemistry. Anti-cancer Agents | Michael Günther; Ernst Wagner; Manfred Ogris | 10.2174/1568011053174855 | 38 |
| 113 | Intracoronary Brachytherapy - Clinical State and Pathophysiological Considerations | Current Pharmaceutical Design | Florian Krötz; Hae-Young Sohn; Volker Klauss; Thomas M. Schiele | 10.2174/1381612053382025 | 8 |
| 114 | Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function. | Current Drug Metabolism | N. Weiss | 10.2174/1389200052997357 | 169 |
| 115 | Vasoprotective actions of the atrial natriuretic peptide. | Current Medicinal Chemistry. Cardiovascular And Hematological Agents | Alexandra K. Kiemer; Robert Fürst; Angelika M. Vollmar | 10.2174/1568016052773333 | 29 |
| 116 | Triplex-forming oligonucleotides - sequence-specific DNA ligands as tools for gene inhibition and for modulation of DNA-associated functions. | Current Drug Targets | Robert Besch; Carine Giovannangeli; Klaus Degitz | 10.2174/1389450043345100 | 51 |
| 117 | Regenerative dendritic spikes and synaptic plasticity. | Current Neurovascular Research | Knut Holthoff | 10.2174/1567202043362144 | 8 |
| 118 | Uncovering γ-Secretase | Current Alzheimer Research | Harald Steiner | 10.2174/1567205043332081 | 34 |
| 119 | Porphyrins as Radiosensitizing Agents for Solid Neoplasms | Current Pharmaceutical Design | Moshe Schaffer; Birgit Ertl-Wagner; P.M. Schaffer; Ulrike Kulka; Alfons Hofstetter; Eckhart Dühmke; Giulio Jori | 10.2174/1381612033454153 | 22 |
| 120 | The Secreted Aspartic Proteinases as a New Target in the Therapy of Candidiasis | Current Drug Targets | M. Bein; M. Schaller; H.C. Korting | 10.2174/1389450023347542 | 20 |
| 121 | Vasculogenesis and angiogenesis depend on the developmental origin in the arterial tree. | Current Medicinal Chemistry | Masumi Shimizu; Jaroslav Pelisek; Sigrid Nikol | 10.2174/0929867023369321 | 19 |
| 122 | Structure based design of benzophenone-based non-thiol farnesyltransferase inhibitors. | Current Pharmaceutical Design | Martin Schlitzer | 10.2174/1381612023394061 | 12 |
Webmaster Contact: info@benthamscience.net